Cardiovascular benefits include significant reductions in systolic and diastolic blood pressure (mean systolic reduction of 9.9 mm Hg in non-diabetic adults and 6.5 mm Hg in those with diabetes), improved lipid profiles, and lower C-reactive protein levels, all of which are relevant for cardiovascular risk reduction
While GLP-1 medications have demonstrated significant efficacy in clinical studies, the rise of over-the-counter supplements poses questions about their effectiveness and safety
This is because mitochondria can work better
These findings indicate that the role of GLP-1RAs varies across different types of tumors, necessitating further investigation
Some patients report that they forget to eat, not out of nausea, but out of genuine absence of hunger signals
That is because conventional lab ranges measure disease, not optimal function